Navigation Links
Peripheral Vascular Device Market Insights Webinar
Date:6/2/2008


WALTHAM, Mass., June 2 /PRNewswire/ --

WHAT: PERIPHERAL VASCULAR DEVICE MARKET INSIGHTS WEBINAR

(audio and online presentation)

WHEN: Thursday, June 5, 2008, 11 am US Eastern Time, 5 pm Central

European Time (Paris)

PRESENTER: Stephanie LaBelle, Analyst from Millennium Research Group

TO ENROLL: Please use the link below to register or call Shiu-Yik Au at

416-364-7776 ext. 123

Millennium Research Group presents a complimentary Webinar outlining our knowledge of the peripheral vascular (PV) device industry. Sign up to gain information derived from our Global Peripheral Vascular Device report series and PV Marketrack(TM).

In this one-hour presentation, our Analyst will discuss numerous PV device market dynamics, including the following:

PV Market Trends

-- Global overview of the PV device market

-- Market focus: Factors included in the US market forecast models

PV Stent Market

-- Effect of indication-specific approvals on the use of stents

-- Highlights of PV practice trends for interventional cardiologists,

interventional radiologists, and vascular surgeons

Inferior Vena Cava Filter Market

-- Market impact of product developments and launches by existing and new

competitors

-- Results of supportive clinical data on device usage patterns

Thoracic Endovascular Aortic Repair (TEVAR) Market

-- Market impact of emerging competitors

A question and answer session will follow the presentation.

To enroll for this event, please use the Internet URL below to reach our WebEx page and then click the "Register" button at the bottom of the page. Once you complete the brief registration form, click "Submit".

https://mrg.webex.com/mrg/onstage/g.php?t=a&d=714156377

If you have any questions concerning your registration, please contact Shiu-Yik Au at 416-364-7776 ext. 123 or at sau@mrg.net.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
2. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
3. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
4. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
5. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
6. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
7. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
8. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
9. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
10. Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
11. Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts ... they believe could be a new and helpful biomarker for malignant pleural mesothelioma. ... here to read it now. , Biomarkers are components in the blood, ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
Breaking Biology Technology:
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
Breaking Biology News(10 mins):